Clinical Trials in Diabetes is the first and only event which tackles the operational challenges of implementing clinical trials in diabetes.
The conference focuses on the hottest topics such as patient recruitment & retention in a fiercely competitive market, adhering to complex and ever-changing regulations and successfully running trials in new and emerging markets.
Conference Highlights
- Case studies from Novo Nordisk and Astrazeneca on successful clinical trial roll out
- Essential insight on resolving issues surrounding patient selection
- Discuss innovative technologies to overcome patient recruitment & retention challenges
- Critical insights on the ever changing regulations for drug approvals
- Strategies for effective communication with key stakeholders for diabetes research and trial implementation
- Top speakers with a wealth of experience in the clinical trials
- Diabetes Research Network highlights matching of diabetes patients with suitable trials
To enquire about attending, contact:
For general enquiries, contact:
Who will I meet?
- Meet key opinion leaders from the top 3 diabetes pioneers – Sanofi-Aventis, Eli Lilly and Novo Nordisk
- Form new partnerships for both large pharmaceutical companies and small biopharmaceutical companies
- Meet people within the industry, academia and health services to get a 360º perspective
- Get advice from those people who have successfully managed to run clinical trials with minimal drop-outs and excellent recruitment figures
This unique opportunity will allow you to network with VPs, Heads and Directors involved in diabetes trials from the leading companies to the smaller specialised manufacturers across Europe and America.
Clinical Trials in Diabetes gives you the prime opportunity to build relationships and learn top tips from the industry experts.
The Venue
Amsterdam is a city that is always buzzing with life 365 days a year. There is much to be discovered from the flower markets to the city’s history.
Spend your days visiting the many delights and lose yourself in its charm. Come join us.
| Name |
Title / Company |
| Riccardo Perfetti |
VP Medical Affairs – Global Diabetes Division at Sanofi- Aventis |
| Sara James |
Global Enrolment Consultant for EUMED at Eli Lilly |
| Robert Pordy |
Head of Therapeutics – Cardiovascular and Metabolism at Regeneron |
| Deborah Price |
Senior Director Clinical Project Management at Astrazeneca |
| Itzik Harosh |
CEO at Obetherapy |
| Jeppe Ragnar Andersen |
Director Head of Clinical Development and Clinical Trials at Nordic Biosciences |
| Paul Thorpe |
Head of Communications at NIHR |
| Martin Gibson |
Honorary Senior Lecturer/Consultant in Diabetes/Endocrinology at NHS Trust |
| Yan Gong |
Director Global Medical Affairs - Metabolism at Boehringer-Ingelheim |
| Shlomo Dagan |
CEO at Adromeda Biotech |
| Randi Rahbaek |
Director of Clinical Operations Degludec at Novo Nordisk |
| Mattias Mahn |
Medical Affairs Manager at Novo Nordisk International Operations A/S |
| A.J. Smit MD PhD |
Department of Medicine, Section for Vascular Medicine / Scientific Director at University Hospital Groningen/Diagnoptics Tehnologies BV |
| Steven E. Cohen, M.D |
Senior Director, External Scientific Affairs, Cardiovascular - Metabolism Translational Medicine and Clinical Pharmacology, CVM at Daiichi Sankyo |
| Christophe Arbet-Engels |
Sr. Medical Director at Hoffmann-La Roche |
| Cristina Rondinone |
Vice President R&D, Head CV/Metabolic Diseases at MedImmune-AZ |
Join us